Catalog No.
YHD03901
Expression system
E. coli
Species
Homo sapiens (Human)
Protein length
Asp401-Ala511
Predicted molecular weight
14.73 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P14314
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Glucosidase II subunit beta, Glucosidase 2 subunit beta, 80K-H protein, G19P1, PKCSH, PRKCSH, Protein kinase C substrate 60.1 kDa protein heavy chain
Potential role of PRKCSH in lung cancer: bioinformatics analysis and a case study of Nano ZnO. PMID: 35254362
Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases. PMID: 29038287
PRKCSH contributes to tumorigenesis by selective boosting of IRE1 signaling pathway. PMID: 31320625
Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies. PMID: 32690722
PRKCSH Alternative Splicing Involves in Silica-Induced Expression of Epithelial-Mesenchymal Transition Markers and Cell Proliferation. PMID: 32425726
PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation. PMID: 19801576
Animal models of biliary injury and altered bile acid metabolism. PMID: 28709963
Down-regulating Circular RNA Prkcsh suppresses the inflammatory response after spinal cord injury. PMID: 34100450
PRKCSH genetic mutation was not found in Taiwanese patients with polycystic liver disease. PMID: 19308730
DDOST, PRKCSH and LGALS3, which encode AGE-receptors 1, 2 and 3, respectively, are not associated with diabetic nephropathy in type 1 diabetes. PMID: 20490454
Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. PMID: 33110154
PRKCSH GAG trinucleotide repeat is a mutational target in gastric carcinomas with high-level microsatellite instability. PMID: 21371016
Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease. PMID: 16835903
Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene. PMID: 26365003
Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease. PMID: 15057895
Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. PMID: 12577059
Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p. PMID: 18224332
Publisher Correction: PRKCSH contributes to tumorigenesis by selective boosting of IRE1 signaling pathway. PMID: 31420557
Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. PMID: 12529853
Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease. PMID: 36573973
Genetics of polycystic liver diseases. PMID: 30652979
Structure of the bovine VASAP-60/PRKCSH gene, functional analysis of the promoter, and gene expression analysis. PMID: 17250974
CircPrkcsh, a circular RNA, contributes to the polarization of microglia towards the M1 phenotype induced by spinal cord injury and acts via the JNK/p38 MAPK pathway. PMID: 34751973
Molecular Mechanisms of Isolated Polycystic Liver Diseases. PMID: 35571028
Genomic diagnostics in polycystic kidney disease: an assessment of real-world use of whole-genome sequencing. PMID: 33437033
Genetics and mechanisms of hepatic cystogenesis. PMID: 28782656
Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63. PMID: 20095989
Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling. PMID: 28973524
Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease. PMID: 21856269
Hepatocystin is Essential for TRPM7 Function During Early Embryogenesis. PMID: 26671672
A 3-Mb region for the familial hemiplegic migraine locus on 19p13.1-p13.2: exclusion of PRKCSH as a candidate gene. Dutch Migraine Genetic Research Group. PMID: 9043864
Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease. PMID: 23209713
Congenital disorders of glycosylation in hepatology: the example of polycystic liver disease. PMID: 20138683
Management of polycystic liver disease. PMID: 15701294
Polycystic disease of the liver. PMID: 15382167
[AGE and AGE-receptors]. PMID: 11321842
Polycystic liver disease: ductal plate malformation and the primary cilium. PMID: 24506938
Active Ca(2+) reabsorption in the connecting tubule. PMID: 18989697
Regulation of TRPV5 and TRPV6 by associated proteins. PMID: 16682485
Isolated polycystic liver disease genes define effectors of polycystin-1 function. PMID: 28375157
GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review. PMID: 35806376
An in vitro model of polycystic liver disease using genome-edited human inducible pluripotent stem cells. PMID: 30172093
Pathways that control cortical F-actin dynamics during secretion. PMID: 12512942
The zebrafish as a model to study polycystic liver disease. PMID: 23668934
Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management. PMID: 24886261
Polycystic liver disease is a disorder of cotranslational protein processing. PMID: 15649821
[Cystic liver diseases. Genetics and cell biology]. PMID: 16294159
What the similarities of specific polycystic liver and kidney diseases can teach us about both. PMID: 18778002
The current understanding of lamotrigine as a mood stabilizer. PMID: 15291656
[From gene to disease; hepatocystin and autosomal dominant polycystic liver disease]. PMID: 12894465
Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks. PMID: 12610644
TRPV5 and TRPV6 in Ca(2+) (re)absorption: regulating Ca(2+) entry at the gate. PMID: 16044309
N-glycosylation determines the abundance of the transient receptor potential channel TRPP2. PMID: 24719335
Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease. PMID: 27259053
The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway. PMID: 12191614
Toward an integrated map of genetic interactions in cancer cells. PMID: 29467179
Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis. PMID: 36246085
A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation. PMID: 21685914
Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease. PMID: 34568801
Prognosis related miRNAs, DNA methylation, and epigenetic interactions in lung adenocarcinoma. PMID: 30868896
Odd skipped-related 1 (Osr1) identifies muscle-interstitial fibro-adipogenic progenitors (FAPs) activated by acute injury. PMID: 30149291
The mitochondrial uncoupling protein 2 gene is causal for the spontaneous polycystic liver diseases in mice. PMID: 29154852
Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing. PMID: 30135240
Somatic second-hit mutations leads to polycystic liver diseases. PMID: 23326178
Sec63 and Xbp1 regulate IRE1α activity and polycystic disease severity. PMID: 25844898
Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes. PMID: 27552964
Deficiency of hepatocystin induces autophagy through an mTOR-dependent pathway. PMID: 21681021
An Integrated Proteomics and Bioinformatics Analysis of the Anticancer Properties of RT2 Antimicrobial Peptide on Human Colon Cancer (Caco-2) Cells. PMID: 35209215
Association of a novel PKHD1 mutation in a family with autosomal dominant polycystic liver disease. PMID: 33569422
TRIM67 protein negatively regulates Ras activity through degradation of 80K-H and induces neuritogenesis. PMID: 22337885
Short-hairpin RNA library: identification of therapeutic partners for gefitinib-resistant non-small cell lung cancer. PMID: 25528770
Differential sensitivity of hepatocellular carcinoma cells to suppression of hepatocystin transcription under hypoxic conditions. PMID: 27640193
Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis. PMID: 24706814
Mutations in SEC63 cause autosomal dominant polycystic liver disease. PMID: 15133510
For research use only. Not for human or drug use.
